MIM
OCGN icon

MetLife Investment Management’s Ocugen OCGN Stock Holding History

MetLife Investment Management’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,769
Closed -$31.6K – 2900
2025
Q1 		$31.6K Sell
44,769
-125,687
-74% -$86.9K ﹤0.01% 2726
2024
Q4 		$137K Buy
170,456
+80,948
+90% +$74.1K ﹤0.01% 2482
2024
Q3 		$88.8K Buy
89,508
+23,877
+36% +$32.8K ﹤0.01% 2669
2024
Q2 		$102K Buy
+65,631
New +$102K ﹤0.01% 2595
2023
Q2 		– Sell
-116,226
Closed -$99.2K – 2974
2023
Q1 		$99.2K Buy
116,226
+45,303
+64% +$49.4K ﹤0.01% 2558
2022
Q4 		$92.2K Sell
70,923
-41,609
-37% -$64.9K ﹤0.01% 2624
2022
Q3 		$200K Hold
112,532
– – ﹤0.01% 2304
2022
Q2 		$255K Buy
112,532
+45,026
+67% +$108K ﹤0.01% 2140
2022
Q1 		$223K Buy
67,506
+1,523
+2% +$5.35K ﹤0.01% 2288
2021
Q4 		$300K Buy
65,983
+9,087
+16% +$68.6K ﹤0.01% 1811
2021
Q3 		$409K Sell
56,896
-10,891
-16% -$79.9K ﹤0.01% 1644
2021
Q2 		$544K Buy
+67,787
New +$572K ﹤0.01% 1518

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MetLife Investment Management's OCGN Position: Q2 2025 in Review

MetLife Investment Management sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 44,769 shares — an estimated $31.6K sold.

MetLife Investment Management first reported a position in OCGN in Q2 2021 and held it in 12 quarters. The position peaked at $544K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • MetLife Investment Management reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • MetLife Investment Management sold 44,769 Ocugen shares in Q2 2025, an estimated $31.6K.
  • MetLife Investment Management first reported a position in Ocugen in Q2 2021 and held it in 12 quarters.
  • MetLife Investment Management's Ocugen position peaked at $544K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.